- Daratumumab, sold
under the
brand name
Darzalex among others, is an anti-cancer
monoclonal antibody medication. It
binds to CD38,
which is overexpressed...
-
metastatic cervical cancer (Seagen)
Marketed by partners:
Darzalex (IV) (daratumumab) /
Darzalex Faspro (SC) (daratumumab and hyaluronidase) for the treatment...
- Daratumumab/hyaluronidase, sold
under the
brand name
Darzalex Faspro, is a fixed-dose
combination medication for the
treatment of
adults with
newly diagnosed...
-
grants accelerated approval to
Darzalex Faspro for
newly diagnosed light chain amyloidosis". FDA. 11 June 2021. "
Darzalex". 17
September 2018. Kastritis...
- lenalidomide) and dexamethasone.
Similarly with DKRd, with the D
representing Darzalex (brand name for daratumumab), and K
representing Kyprolis (brand name for...
- 2023, the
Institute for
Clinical and
Economic Review (ICER)
identified Darzalex (daratumumab),
developed by
Johnson &
Johnson as one of five high-expenditure...
- ISBN 978-1-4160-2973-1. 8th edition. "FDA
grants accelerated approval to
Darzalex Faspro for
newly diagnosed light chain amyloidosis". U.S. Food and Drug...
-
Topamax Trevicta Xeplion Oncology therapies Balversa Carvykti Dacogen Darzalex Eprex Erleada Imbruvica Procrit Rybrevant Talvey Tecvayli Valchlor Velcade...
- 11
August 2020.
Retrieved 23
January 2020. "
Darzalex-
daratumumab injection, solution,
concentrate Darzalex IV-
daratumumab injection, solution, concentrate"...
- trastuzumab/hyaluronidase-oysk (Herceptin Hylecta), daratumumab/hyaluronidase-fihj (
Darzalex Faspro), pertuzumab/trastuzumab/hyaluronidase–zzxf (Phesgo). In July 2021...
